CompletedEarly Phase 1NCT03291990

5 Fraction Stereotactic Radiosurgery With Temozolomide for Glioblastoma Multiforme

Studying Germ cell tumor

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Principal Investigator
Lawrence Kleinberg, MD
SKCCC at Johns Hopkins (East Baltimore)
Intervention
Temozolomide(drug)
Enrollment
3 target
Eligibility
18-100 years · All sexes
Timeline
2017 – 2020

Study locations (3)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03291990 on ClinicalTrials.gov

Other trials for Germ cell tumor

Additional recruiting or active studies for the same condition.

See all trials for Germ cell tumor →

← Back to all trials